Core Viewpoint - The article emphasizes the importance of recognizing obesity as a disease and the need for scientific weight management methods, highlighting the psychological barriers faced by individuals struggling with obesity [2][3][9]. Group 1: Obesity as a Disease - The World Health Organization defined obesity as a disease as early as 1997, yet many individuals do not seek medical help until serious health issues arise [3][9]. - In China, nearly 100 million individuals aged 5-19 have a high BMI (BMI ≥ 25 kg/m²), and over 50% of adults are classified as overweight or obese [3]. Group 2: Psychological Barriers - Many individuals with obesity are reluctant to seek medical assistance due to societal stigma and the belief that obesity is a personal failing rather than a medical condition [9][11]. - Patients often experience significant psychological pressure and may suffer from depression due to societal perceptions of obesity [11][12]. Group 3: Treatment Approaches - Traditional weight loss methods often lead to weight regain, with studies indicating that about 50% of weight lost through lifestyle changes is regained within two years, and up to 80% by five years [10]. - The introduction of GLP-1 (glucagon-like peptide-1) medications has been seen as a breakthrough in obesity treatment, providing a scientifically backed option for weight management [14][17]. Group 4: Long-term Management - Long-term weight management is crucial, as highlighted by the 2024 guidelines from the Chinese Medical Association, which stress the importance of ongoing assessment and support after initial weight loss [21][22]. - The article advocates for a multidisciplinary approach to obesity treatment, integrating various medical specialties to provide comprehensive care for patients [28]. Group 5: Impact of GLP-1 Medications - GLP-1 medications have gained popularity in the medical community for their effectiveness in weight loss and potential benefits for related health conditions, including cardiovascular diseases [26][27]. - The use of GLP-1 medications has changed patient perceptions, encouraging more individuals to seek medical help for obesity [17][25].